HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever

This article was originally published in The Rose Sheet

Executive Summary

Acquires Nautica fragrance and beauty product global license under agreement announced March 30. New product development will be headed by Unilever's Home and Personal Care division. The designer had been shopping the license around following Paul Sebastian's purchase of inventory and distribution rights in January ("The Rose Sheet" Jan. 25, p. 10). Existing scents include Nautica (1992), Nautica for Women (1997) and Nautica Competition (1997). The designer license will join Unilever's Calvin Klein and Elizabeth Arden prestige fragrance and cosmetics brands. Nautica said it was looking for a multinational marketer for the line

You may also be interested in...



Nautica Charts Course For Latitude Longitude Men's Fragrance

Unilever Prestige navigates Nautica fragrance license launch with Latitude Longitude men's scent. The first project under Unilever's prestige fragrance unit, Latitude Longitude bows in July.

Nautica Charts Course For Latitude Longitude Men's Fragrance

Unilever Prestige navigates Nautica fragrance license launch with Latitude Longitude men's scent. The first project under Unilever's prestige fragrance unit, Latitude Longitude bows in July.

Unilever Prestige Licensing Deals Sought Via New Marketing Unit

Unilever will boost its presence in the upscale fragrance and beauty market with the development of a new business unit, Unilever Prestige, the company announced March 7.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006520

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel